Content about Pharmaceuticals policy

October 27, 2010

Risks of counterfeiting, contamination and intellectual property theft could increase with the globalization of the...

NEW YORK Risks of counterfeiting, contamination and intellectual property theft could increase with the globalization of the pharmaceutical supply chain, according to a new report.

October 26, 2010

U.S. Marshals earlier this month seized articles of prescription and over-the-counter drug products from Tri-Med...

October 24, 2010

The Food and Drug Administration declined to approve a regulatory approval application from Arena Pharmaceuticals...

SAN DIEGO The Food and Drug Administration declined to approve a regulatory approval application from Arena Pharmaceuticals and Eisai for a drug to treat obesity, the two companies said Saturday.

 

The FDA issued a complete response letter for the drug lorcaserin, designed for weight management and weight loss in patients who are overweight or obese and have at least one co-morbid condition. The FDA issues a complete response letter when it finishes reviewing an approval application, but issues remain that preclude final approval.

 

October 24, 2010

With strong support from pharmacy leaders, Congress is moving to shut down prescription medication abuse...

With strong support from pharmacy leaders, Congress is moving to shut down prescription medication abuse and diversion with a multipronged legislative cudgel.

Prior to its October recess, the U.S. House of Representatives passed three industry-backed bills in September to help seal up the nation’s leaky prescription drug pipeline. The bills are expected to pass under “suspension of the rules,” which allows for expedited consideration of legislation.

October 24, 2010

More than a quarter trillion dollars in pharmaceutical sales happened through primary healthcare distributors in...

October 24, 2010

Independent pharmacies in 2009 generally were able to withstand the pummeling of a major recession,...

October 24, 2010

Speculation has emerged that Eli Lilly may seek to acquire several other companies in light...

NEW YORK Speculation has emerged that Eli Lilly may seek to acquire several other companies in light of its difficulties winning approval for a long-acting diabetes treatment, according to published reports.

 

October 24, 2010

Some say it cheapens patient care and reduces quality. The nation’s fourth-biggest pharmacy retailer and...

October 20, 2010

K-V Pharmaceutical has created a new marketing subsidiary for generic drugs, the company said Wednesday....

ST. LOUIS K-V Pharmaceutical has created a new marketing subsidiary for generic drugs, the company said Wednesday.

 

K-V announced the establishment of Nesher Pharmaceuticals, appointing as its president Mark Hartman, who has had several positions in generic drug companies.

 

 

October 20, 2010

The Food and Drug Administration has approved a Mylan generic drug for Parkinson’s disease, Mylan...

PITTSBURGH The Food and Drug Administration has approved a Mylan generic drug for Parkinson’s disease, Mylan said Thursday.

 

The drug maker announced the approval of pramipexole dihydrochloride tablets in the 0.125-mg, 0.25-mg, 0.5-mg, 1-mg and 1.5-mg strengths. The drug is a generic version of Boehringer Ingelheim’s Mirapex.

 

 

October 20, 2010

The Food and Drug Administration could decide that some generic drugs are not equivalent to...

BETHESDA, Md. The Food and Drug Administration could decide that some generic drugs are not equivalent to their branded counterparts, according to published reports.

 

October 19, 2010

A drug store chain and a leading provider of mobile drug reference tools and interactive...

October 18, 2010

It’s a ruling that could bolster the retail pharmacy industry’s long campaign to extend full...

October 18, 2010

The National Association of Chain Drug Stores on Tuesday released a letter addressed to the...

October 18, 2010

Drug maker Purdue Pharma has donated $200,000 to the National Association of State Controlled Substances...

CHARLESTON, S.C. Drug maker Purdue Pharma has donated $200,000 to the National Association of State Controlled Substances Authorities to address the abuse of prescription drugs, NASCSA said Tuesday.

 

The grant, presented at the group’s annual conference in Charleston, S.C., is designed to support state prescription drug monitoring programs. The NASCSA will be in charge of distributing the money to state agencies. Purdue is the maker of OxyContin (oxycodone), a commonly abused prescription opioid painkiller.

 

 

October 17, 2010

Spurred by a difficult economy, over-the-counter medications increasingly are playing a dual role for consumers...

CHICAGO Spurred by a difficult economy, over-the-counter medications increasingly are playing a dual role for consumers looking to minimize healthcare expenditures, the SymphonyIRI Group found in a new research paper titled “Over-the-Counter Medications: State of the Industry 2010” that was released last week.

 

October 17, 2010

The Food and Drug Administration granted approval for Teva's abbreviated new drug application to market...

JERUSALEM The Food and Drug Administration granted approval for Teva's abbreviated new drug application to market a generic version of a drug designed to treat peptic ulcers.

The generic drug maker said that its drug, lansoprazole, is a generic version of Takeda’s Prevacid SoluTab. Annual sales of the branded product were approximately $453 million in the United States, according to IMS sales data.

Sandoz, the generics division of Swiss drug maker Novartis, also announced the launch of its own version of Prevacid SoluTab.

October 14, 2010

A plan by health insurer Humana and Walmart to offer a cheap prescription drug plan...

WHAT IT MEANS AND WHY IT'S IMPORTANT A plan by health insurer Humana and Walmart to offer a cheap prescription drug plan to seniors who shop at the mass merchandiser may be a little off the mark, if results of the survey of Medicare beneficiaries is to be believed.

(THE NEWS: Many seniors are satisfied with Medicare Rx benefit, survey shows. For the full story, click here)

October 14, 2010

The Food and Drug Administration has approved a Watson Pharmaceuticals generic drug for treating high...

MORRISTOWN, N.J. The Food and Drug Administration has approved a Watson Pharmaceuticals generic drug for treating high blood pressure, Watson said Friday.

 

The company announced the FDA approval of amlodipine besylate and benazepril capsules in the 5/20-mg, 10/20-mg, 2.5/10-mg and 5/10-mg strengths.

 

 

The drug is a generic version of Novartis’ Lotrel. Branded and generic versions of the drug had sales of around $1.05 billion during the 12-month period ended in June, according to IMS Health.

 

October 13, 2010

CVS Caremark is presenting data at the Academy of Managed Care Pharmacy 2010 Educational Conference...

WOONSOCKET, R.I. CVS Caremark is presenting data at the Academy of Managed Care Pharmacy 2010 Educational Conference illustrating how innovative approaches to traditional plan designs can help clients reduce drug spend, improve generic dispensing rates and minimize member disruption.

The AMCP 2010 Educational Conference is being held in St. Louis from Oct. 13 to 15.

October 12, 2010

A panel of healthcare thought leaders has concluded that a recent IRS rule change requiring...

October 12, 2010

Lupin Pharmaceuticals received regulatory approval last week for its generic antihypertensive agents, the drug maker...

BALTIMORE, Md. Lupin Pharmaceuticals received regulatory approval last week for its generic antihypertensive agents, the drug maker said.

Lupin was granted final approval for hydrochlorothiazide-losartan potassium and losartan potassium, the generic versions of Merck's Hyzaar and Cozaar.

Hyzaar and Cozaar had combined annual sales of approximately $1.6 billion in the United States, based on IMS sales data for the 12 months ended in June.

October 11, 2010

Actavis has received regulatory approval from the Food and Drug Administration for its high blood...

MORRISTOWN, N.J. Actavis has received regulatory approval from the Food and Drug Administration for its high blood pressure drug.

 

The drug maker said its losartan potassium tablets, USP, will be available in 25-mg, 50-mg and 100-mg strengths. The drug is a generic version of Merck's Cozaar.

 

 

Losartan potassium tablets, USP, had sales of approximately $940 million for the 12 months ended June 30, according to IMS Health.

 

October 11, 2010

The Medicare prescription drug benefit continues to enjoy strong support among the country’s seniors, according...

October 10, 2010

The new prescription requirement for over-the-counter medicines under flexible spending accounts, part of the new...

WASHINGTON Drug Store News, for the simple reason that the change actually hurts the people health reform was supposed to help—patients looking to save money on healthcare costs. —The new prescription requirement for over-the-counter medicines under flexible spending accounts, part of the new Affordable Care Act, may amount to bad medicine, many industry pundits have told

And the ramifications of that simple requirement also will be felt across the retail pharmacies that those in search of healthcare savings patronize.